In conclusion, we explored the role of CD45 in ALK+ ALCL and demonstrated that CD45 downregulation depends by NPM-ALK activity in ALK+ ALCL and that its depletion leads to ALK-TKI resistance. The gene discussed is PTPRC; the disease is anaplastic large cell lymphoma.